Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
- 1 May 1988
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 94 (5), 1186-1192
- https://doi.org/10.1016/0016-5085(88)90011-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical Experience with Charcoal and Resin HemoperfusionSeminars in Liver Disease, 1986
- Orthotopic liver transplantation for acute fulminant Wilson diseaseThe Journal of Pediatrics, 1985
- Utilization of Activated Carbon Hemoperfusion to Assist Recovery of Ischemically Damaged Canine Liver AllograftsArtificial Organs, 1985
- Acute hepatic failure. In special relation to treatment.Japanese Journal of Medicine, 1983
- EARLIER CHARCOAL HAEMOPERFUSION IN FULMINANT HEPATIC FAILUREThe Lancet, 1982
- Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.Gut, 1982
- Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.Gut, 1981
- PROSTACYCLIN TO PREVENT PLATELET ACTIVATION DURING CHARCOAL HÆMOPERFUSION IN FULMINANT HEPATIC FAILUREThe Lancet, 1980
- Artificial Liver: The Effect of ACAC Microencapsulated Charcoal Hemoperfusion on Fulminant Hepatic FailureArtificial Organs, 1977
- CHARCOAL HÆMOPERFUSION IN THE TREATMENT OF FULMINANT HEPATIC FAILUREThe Lancet, 1974